Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Optimal Initial Treatment Duration of Bevacizumab in Combination With Standard Chemotherapy in Patients With Ovarian Cancer (BOOST)
This study is ongoing, but not recruiting participants.
Study NCT01462890   Information provided by AGO Study Group

First Received on October 25, 2011.   Last Updated on March 4, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial